HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $721,407 | +3.1% | 18,885 | -2.6% | 0.01% | +11.1% |
Q2 2023 | $699,433 | -12.6% | 19,391 | -7.5% | 0.01% | -25.0% |
Q1 2023 | $800,424 | -32.6% | 20,959 | +0.4% | 0.01% | -36.8% |
Q4 2022 | $1,187,389 | +40.7% | 20,868 | -2.3% | 0.02% | +18.8% |
Q3 2022 | $844,000 | -9.8% | 21,352 | +0.3% | 0.02% | -15.8% |
Q2 2022 | $936,000 | +14.0% | 21,284 | +3.4% | 0.02% | +35.7% |
Q1 2022 | $821,000 | -1.0% | 20,593 | -0.1% | 0.01% | +7.7% |
Q4 2021 | $829,000 | -4.1% | 20,607 | -3.0% | 0.01% | -18.8% |
Q3 2021 | $864,000 | -11.4% | 21,239 | -1.1% | 0.02% | -11.1% |
Q2 2021 | $975,000 | +67.2% | 21,477 | +53.7% | 0.02% | +50.0% |
Q1 2021 | $583,000 | -19.9% | 13,975 | -18.0% | 0.01% | -25.0% |
Q4 2020 | $728,000 | – | 17,040 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |